Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 207 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
TNFSF13B
💬1. TNFSF13B
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis 4件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Belimumab
Belimumab
💬1. TNFSF13B
| Belimumab | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬1. TNFSF13B
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
TNFSF13B
💬2. TNFSF13B
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis 4件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Atacicept
Atacicept
💬2. TNFSF13B
| Atacicept | 4件: 13 13, 46, 49, 66 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
TNFSF13B
💬3. TNFSF13B
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis 4件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Tabalumab
Tabalumab
💬3. TNFSF13B
| Tabalumab | 2件: 46 46, 49 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
TNFSF13B
💬4. TNFSF13B
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis 4件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network ... | Tibulizumab
Tibulizumab
💬4. TNFSF13B
| Tibulizumab | 1件: 53 53 💬4. TNFSF13B
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
CPS1
💬5. CPS1
| 6件: Arginine biosynthesis Arginine biosynthesis, Alanine, aspartate and glutamate metabolism, Nitrogen metabolism, Metabolic pathways, Carbon metabolism, Biosynthesis of amino acids 6件: Arginine biosynthesis, Alanine, aspartate and glutamate metabolism, Nitrogen metabolism, Metabol ... | Carglumic acid
Carglumic acid
💬5. CPS1
| Carglumic acid | 3件: 245 245, 246, 251 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
CSF2
💬6. CSF2
| 16件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Shigellosis, Amoebiasis, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Coronavirus disease - COVID-19, Transcriptional misregulation in cancer, Acute myeloid leukemia, Rheumatoid arthritis 16件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, ... | Otilimab
Otilimab
💬6. CSF2
| Otilimab | 1件: 46 46 💬6. CSF2
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
CTLA4
💬7. CTLA4
| 4件: Cell adhesion molecules Cell adhesion molecules, T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumatoid arthritis 4件: Cell adhesion molecules, T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumato ... | Ipilimumab
Ipilimumab
💬7. CTLA4
| Ipilimumab | 1件: 159 159 💬7. CTLA4
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
CTLA4
💬8. CTLA4
| 4件: Cell adhesion molecules Cell adhesion molecules, T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumatoid arthritis 4件: Cell adhesion molecules, T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumato ... | Tremelimumab
Tremelimumab
💬8. CTLA4
| Tremelimumab | 1件: 96 96 💬8. CTLA4
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
DMD
💬9. DMD
| 4件: Hypertrophic cardiomyopathy Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Viral myocarditis 4件: Hypertrophic cardiomyopathy, Arrhythmogenic right ventricularcardiomyopathy, Dilated cardiomyopa ... | Eteplirsen
Eteplirsen
💬9. DMD
| Eteplirsen | 1件: 113 113 💬9. DMD
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 |
DMD
💬10. DMD
| 4件: Hypertrophic cardiomyopathy Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Viral myocarditis 4件: Hypertrophic cardiomyopathy, Arrhythmogenic right ventricularcardiomyopathy, Dilated cardiomyopa ... | Drisapersen
Drisapersen
💬10. DMD
| Drisapersen | 1件: 113 113 💬10. DMD
|